Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Owlet (OWLT) Interest & Investment Income (2020 - 2022)

Owlet (OWLT) reported Interest & Investment Income of -$419000.0 for Q3 2022, up 12.16% year-over-year from -$373575.7 in Q3 2021, and up 12.16% on a QoQ basis from -$477000.0 in Q3 2021.

Owlet (OWLT) has 3 years of Interest & Investment Income data on file, last reported at -$419000.0 in Q3 2022.

  • Quarterly Interest & Investment Income rose 12.16% year-over-year to -$419000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$852875.0 (down 124.07% YoY) and the FY2025 annual result came in at -$3.4 million, down 109.69% from the prior year.
  • Interest & Investment Income advanced to -$419000.0 in Q3 2022 per OWLT's latest filing, from -$477000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $53249.0 in Q4 2020 and bottomed at -$477000.0 in Q3 2021.
  • The 3-year median for Interest & Investment Income is $5945.0 (2020), against an average of -$132245.7.
  • The widest annual swing landed in 2021, when Interest & Investment Income sank 7853.58%; it then advanced 12.16% in 2022.
  • Tracing OWLT's Interest & Investment Income over 3 years: stood at $53249.0 in 2020, then slumped by 995.79% to -$477000.0 in 2021, then rose by 12.16% to -$419000.0 in 2022.
  • Per Business Quant, the three latest OWLT Interest & Investment Income figures stand at -$419000.0 (Q3 2022), -$477000.0 (Q3 2021), and $5738.0 (Q2 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 106.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 33.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -25.76 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Owlet 150.10 Mn 109.09 Mn 12.24 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 -419,000.00
Sep 30, 2021 -477,000.00
Jun 30, 2021 5,738.00
Mar 31, 2021 37,387.00
Dec 31, 2020 53,249.00
Sep 30, 2020 6,152.00